amantadine has been researched along with levorphanol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almonte, A; Balster, R; Barber, J; Dravid, SM; Erreger, K; French, A; Le, P; Lyuboslavsky, P; Mosely, C; Murray, E; Murray, TF; Nicholson, K; Traynelis, SF; Yuan, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for amantadine and levorphanol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for amantadine and levorphanol
| Article | Year |
|---|---|
Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block.
Topics: Animals; Cell Line; Dizocilpine Maleate; Electrophysiology; Excitatory Amino Acid Antagonists; Humans; Hydrogen-Ion Concentration; Ion Channel Gating; Ion Channels; Male; Mice; Mice, Inbred C57BL; Patch-Clamp Techniques; Protons; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Recombinant Proteins; Stereoisomerism; Xenopus laevis | 2007 |